Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane H Buckner

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Arthritis and Rheumatism|May 14, 2011
Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsOmri Snir, Mary Rieck, John A Gebe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
The Journal of Clinical Investigation|November 5, 2003
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cellsMindi R Walker, Deborah J Kasprowicz, Vivian H Gersuk, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotypeJames D Lord, S Alice Long, Donna M Shows, et al.
Plos Pathogens|September 26, 2007
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activityBeth K Thielen, Kevin C Klein, Lorne W Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cellsPaul L Bollyky, James D Lord, Susan A Masewicz, et al.
Science Immunology|April 1, 2018
Response to comment on "Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis"Carmelo Carmona-Rivera, Kevin L Bicker, Paul R Thompson, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapiesCatherine Sniezek, Deanna Plubell, Katarina Vlajic, et al.
Annals of the Rheumatic Diseases|May 3, 2025
Functional dissection of noncoding variants associated with rheumatoid arthritisAjay Jajodia, Arpit Mishra, Naresh Doni Jayavelu, et al.
Clinical and Experimental Immunology|November 4, 2024
Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patientsCliff Rims, Hannes Uchtenhagen, Kadin Brooks, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|May 14, 2011
Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsOmri Snir, Mary Rieck, John A Gebe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
The Journal of Clinical Investigation|November 5, 2003
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cellsMindi R Walker, Deborah J Kasprowicz, Vivian H Gersuk, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotypeJames D Lord, S Alice Long, Donna M Shows, et al.
Plos Pathogens|September 26, 2007
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activityBeth K Thielen, Kevin C Klein, Lorne W Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cellsPaul L Bollyky, James D Lord, Susan A Masewicz, et al.
Science Immunology|April 1, 2018
Response to comment on "Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis"Carmelo Carmona-Rivera, Kevin L Bicker, Paul R Thompson, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapiesCatherine Sniezek, Deanna Plubell, Katarina Vlajic, et al.
Annals of the Rheumatic Diseases|May 3, 2025
Functional dissection of noncoding variants associated with rheumatoid arthritisAjay Jajodia, Arpit Mishra, Naresh Doni Jayavelu, et al.
Clinical and Experimental Immunology|November 4, 2024
Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patientsCliff Rims, Hannes Uchtenhagen, Kadin Brooks, et al.
Pageof 18